Evidence map›Paper›PMID 33159105›Full record

ArticleScientific reports2020

Ganoderma lucidum Rhodiola compound preparation prevent D-galactose-induced immune impairment and oxidative stress in aging rat model.

Shuo Yuan, Yong Yang, Jiao Li, Xiaoyu Tan, Yuying Cao, Shaoheng Li, Hee-Do Hong, Liping Liu, Qinggao Zhang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. A comparative study of anti-aging effects ofJournal of clinical and translational research · 2022
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Shuo YuanChronic Diseases Research Center, Dalian University College of Medicine, Dalian, 116622, Liaoning, China.
Yong YangChronic Diseases Research Center, Dalian University College of Medicine, Dalian, 116622, Liaoning, China.
Jiao LiChronic Diseases Research Center, Dalian University College of Medicine, Dalian, 116622, Liaoning, China.
Xiaoyu TanXinhua Hospital Affiliated of Dalian University, Dalian, 116021, Liaoning, China.
Yuying CaoChronic Diseases Research Center, Dalian University College of Medicine, Dalian, 116622, Liaoning, China.
Shaoheng LiChronic Diseases Research Center, Dalian University College of Medicine, Dalian, 116622, Liaoning, China.
Hee-Do HongKorea Food Research Institute, Sungnam-si, South Korea.
Liping LiuChronic Diseases Research Center, Dalian University College of Medicine, Dalian, 116622, Liaoning, China. 1106548638@qq.com.
Qinggao ZhangChronic Diseases Research Center, Dalian University College of Medicine, Dalian, 116622, Liaoning, China. zhangqinggao@dlu.edu.cn.
Dalian University · CNKorea Food Research Institute · KRYanbian University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is an irreversible process. This research aims to study the anti-aging effects of GRCP, a compound preparation made by Ganoderma lucidum and Rhodiola rosen, in aging rats. Rats were subcutaneously injected with 400 mg/kg of D-galactose daily, and aging could be induced after 8 weeks. The aging rats were treated with GRCP. This experiment was divided into 6 groups. Rats were randomly divided into the model group, positive control group, low-dose GRCP group (25 mg/kg body weight), medium-dose GRCP group (50 mg/kg body weight), and high-dose GRCP group (100 mg/kg body weight), healthy and normal rats were used as blank controls. After the end, the results show that the use of GRCP at a dose of 100 mg/kg is the best treatment for improving aging rats. Rats gained weight, spleen and thymus indexes, and splenocyte proliferation improved, and inflammatory cytokine levels decreased. Besides, biochemical indicators show that GRCP can improve the antioxidant enzyme activity and reduce the content of lipofuscin and TGF-β in aging rats (P < 0.05). GRCP can also inhibit the activation of the MyD88/NF-κB pathway in rat hippocampus. These results seem to suggest that GRCP can be used as a potential natural supplement or functional food to prevent aging.

Indexed as

Oxidative StressAgingAnimalsGalactoseMalePlant ExtractsRatsRats, Sprague-DawleyReishiRhodiolaGalactosePlant Extracts

Identifiers

PMID33159105
PMCPMC7648061
OpenAlexW3097159038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.